Inimmune to present an Update on Clinical Stage Vaccine Adjuvant and Immunotherapy Programs at the World Vaccine Congress in Washington DC on April 1st
MISSOULA, Montana, April 1, 2024 – Inimmune, a leading biotech company focused on the development of novel vaccine adjuvants, immunotherapies and delivery systems, announced today that its Chief Scientific and Strategy Officer, Jay Evans, Ph.D., will present a talk titled ” Alternative uses for adjuvants & cross-over immunotherapy technologies” at the World Vaccine Congress, in Washington […]
